• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> AGR2 Antibody

AGR2 Antibody [clone AGR2105] (N1053)

  Catalog No Formulation Size Price (USD)  
Image N1053-100UG 0.5 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide 100 ug 329
Image
N1053-25UG 0.5 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced), 0.05% sodium azide 25 ug 155
Western blot testing of human samples with AGR2 antibody at 5ug/ml. Expected molecular weight: 17-20 kDa.
IHC testing of human stomach with AGR2 antibody at 4ug/ml.
Species Reactivity Human, Mouse
Format Purified
Clonality Monoclonal (mouse origin)
Isotype Mouse IgG1, kappa
Clone Name AGR2105
Purity Protein G affinity chromatography
Buffer 1X PBS, pH 7.4
Gene ID 10551
Localization Cytoplasmic
Applications Western blot : 4-8ug/ml
Immunohistochemistry (FFPE) : 3-5ug/ml
Limitations This AGR2 antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

AGR2 (Anterior gradient protein 2 homolog) is thought to promote breast tumorigenesis and is overexpressed in breast cancer cells. High levels of AGR2 indicate a poor prognosis. This suggests it may serve as a useful prognostic indicator and marker of breast cancer metastasis.

Application Notes

Provided assay concentrations are suggestions only, AGR2 antibody titration may be required for optimal results.

Immunogen

A recombinant protein fragment from the N-terminal region of human AGR2 was used as the immunogen for this antibody.

Storage

Aliquot the AGR2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Alternate Names

anterior gradient 2, AG-2, GOB4

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.